Taro Pharm Inds Company Profile

✉ Email this page to a colleague

What is the competitive landscape for TARO PHARM INDS, and what generic and branded alternatives to TARO PHARM INDS drugs are available?

TARO PHARM INDS has twelve approved drugs.

There are three tentative approvals on TARO PHARM INDS drugs.

Summary for Taro Pharm Inds

US Patents:	0
Tradenames:	10
Ingredients:	10
NDAs:	12

Drugs and US Patents for Taro Pharm Inds

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro Pharm Inds	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE	enalapril maleate; hydrochlorothiazide	TABLET;ORAL	075788-001	Sep 18, 2001	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Taro Pharm Inds	CARBAMAZEPINE	carbamazepine	TABLET, CHEWABLE;ORAL	075687-002	Jul 29, 2002		RX	No	Yes		⤷ Subscribe				⤷ Subscribe
Taro Pharm Inds	HYDROCORTISONE BUTYRATE	hydrocortisone butyrate	SOLUTION;TOPICAL	076364-001	Jan 14, 2004	AT	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.